Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol vs Metoprolol for Post-Op Hemodynamic Control in Vascular Surgery
NCT01404767Phase 4Terminated
- Sponsor
- University Health Network
- Start
- Apr 2011
- Primary completion
- Apr 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esmolol in vascular disease, hypertension (HTN), angina pectoris and 1 more (2 arms), sponsored by University Health Network. Primary endpoint: Difference between plasma levels of metoprolol within two groups at 24 hours. Started Apr 2011; status: terminated.
02
Drugs
esmolol
03
Conditions
vascular diseasehypertension (HTN)angina pectorisheart disease
Beyond the preview
Go deeper on NCT01404767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01404767.